Based on this finding, LARGE1 levels were further studied in CSF and serum samples derived from pediatric SMA patients (pre-symptomatic as well as type 1, 2 and 3) and derived from adult SMA type 3 patients by enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene LARGE1 and proximal spinal muscular atrophy.